GreenLight Biosciences Holdings PBC operates as a biotechnology company, which makes ribonucleic acid (RNA) products for human therapies and agriculture. Its breakthrough biomanufacturing platform is engaged in discovering, developing, scaling, and commercializing RNA solutions at volume across multiple sectors in the agricultural and human health markets. The company is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GreenLight Biosciences Holdings PBC?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GreenLight Biosciences Holdings PBC market cap is $45.43M.
What is the 52-week high for GreenLight Biosciences Holdings PBC?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GreenLight Biosciences Holdings PBC 52 week high is $5.89 as of November 25, 2025.
What is the 52-week low for GreenLight Biosciences Holdings PBC?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GreenLight Biosciences Holdings PBC 52 week low is $0.1768 as of November 25, 2025.
What is GreenLight Biosciences Holdings PBC stock price today?
GreenLight Biosciences Holdings PBC stock price today is $0.3002.
What was GreenLight Biosciences Holdings PBC stock price yesterday?
GreenLight Biosciences Holdings PBC stock price yesterday was $0.2996.
What is the PE ratio of GreenLight Biosciences Holdings PBC?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GreenLight Biosciences Holdings PBC’s P/E ratio is -0.26.
What is the Price-to-Book ratio of GreenLight Biosciences Holdings PBC?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GreenLight Biosciences Holdings PBC P/B ratio is 2.0709.
What is GreenLight Biosciences Holdings PBC's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. GreenLight Biosciences Holdings PBC's EBITDA is -0.79.
What is the 50-day moving average of GreenLight Biosciences Holdings PBC?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GreenLight Biosciences Holdings PBC 50-day moving average is $0.2702.
